Research site

Sal Med S.R.L.

Romania Block P7 Scara E Etaj P, Strada Traian, 110424 Pitesti, Romania

6 trials recruiting
Cardiac failure · Atrial fibrillation · Arteriosclerosis
Adult patients

About Specializations

Sal Med S.R.L. in Pitesti, Romania specialises in clinical trials of conditions such as Cardiac failure, Atrial fibrillation, Arteriosclerosis, Cardiovascular disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for atherosclerotic cardiovascular disease (ASCVD). The center's research aims to improve patient outcomes by exploring new therapeutic avenues.

Prevention of cardiovascular events
Innovative lipid-lowering therapies
Advanced management of vascular diseases

Through its cutting-edge research, the center contributes significantly to the understanding and management of cardiovascular conditions, offering hope for improved quality of life for patients worldwide.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Block P7 Scara E Etaj P, Strada Traian110424 PitestiRomania

Open in maps ↗

Recruiting now: 6 trials
Conditions studied: 17

More sites in Pitesti Romania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

17 clinical trials

Cardiovascular disorder+2

Recruiting

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Bi 690517
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Cardiac failure

Recruiting

Registered drug

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Bi 690517
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Recruiting

Investigational

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Finerenone
Sponsor:Colorado Prevention Center

Contact Research Centre

Atrial fibrillation

Recruiting

Investigational

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational

Romania

Participants:65+ years
Substances:Abelacimab
Sponsor:Anthos Therapeutics Inc.

Contact Research Centre

Cardiac failure

Recruiting

Registered drug

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Bi 690517
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Cardiac failure chronic+1

Recruiting

Registered drugNo placebo

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Ferric Derisomaltose
Sponsor:Pharmacosmos A/S

Contact Research Centre

Cardiac failure

Not recruiting

Investigational

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:Novo Nordisk A/S

Contact Research Centre

Familial hypertriglyceridaemia+1

Not recruiting

Investigational

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Isis 678354 Sodium Salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Dyslipidaemia

Not recruiting

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Evolocumab
Sponsor:Amgen Inc.

Contact Research Centre

Arteriosclerosis

Not recruiting

Registered drug

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Novartis Pharma AG

Contact Research Centre

Acute coronary syndrome

Not recruiting

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Janssen - Cilag International

Contact Research Centre

Atrial fibrillation

Not recruiting

Registered drug

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa
Sponsor:Janssen - Cilag International

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites